Literature DB >> 35068782

Do Natural Portosystemic Shunts Need to Be Compulsorily Ligated in Living Donor Liver Transplantation?

Aarathi Vijayashanker1, Bhargava R Chikkala1, Roshan Ghimire1, Ravindra Nidoni1, M Rajgopal Acharya1, Yuktansh Pandey1, Rajesh Dey1, Shahnawaz B Kaloo1, Shaleen Agarwal1, Subhash Gupta1.   

Abstract

BACKGROUND: Natural portosystemic shunt ligation practices in liver transplant vary widely across transplant centres and are frequently undertaken to prevent the serious consequence of portal steal phenomenon. No concrete indications have so far been convincingly identified for their management in living donor liver transplant.
METHODS: We retrospectively studied the outcome of 89 cirrhotic patients who either did (n = 63) or did not (n = 25) undergo shunt ligation during living donor liver transplantation between 2017 and 2020.
RESULTS: The incidence of early allograft dysfunction/nonfunction (P = 1.0) and portal venous complications (P = 0.555) were similar between the two groups. Although overall complications, biliary complications, and the composite of Grade III and IV complications were significantly higher in the nonligated group (P = 0.015, 0.052 and 0.035), 1- year graft and patient survival were comparable between them (P = 0.524).
CONCLUSION: We conclude that shunt ligation in living donor liver transplantation may not always be necessary if adequate portal flow, good vascular reconstruction, and good graft quality have been ensured.
© 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AKI, Acute Kidney Injury; BCS, Budd Chiari Syndrome; BMI, Body mass index; C, Caudate; CIT, Cold ischemia time; EAD, Early Allograft Dysfunction; FLR, Future Liver Remnant; GRWR, Graft Recipient Weight Ratio; HAT, Hepatic Artery Thrombosis; HBV, Hepatitis B virus infection; HCV, Hepatitis C virus infection; HE, Hepatic encephalopathy; HRS, Hepatorenal syndrome; HVOTO, Hepatic venous outflow obstruction; IHV, Inferior hepatic vein; IVC, Infrahepatic Vena Cava; LAI, Liver Attenuation Index; LDLT, Living Donor Liver Transplant; LL, Left lobe; MELD, Model for End-stage Liver Disease; MHV, Middle Hepatic Vein; MRL, Modified Right lobe; NASH, Nonalcoholic steatohepatitis; PVT, Portal Vein Thrombosis; RHV, Right Hepatic Vein; SFSS, Small For Size Syndrome; SMV, Superior mesenteric vein; SRL, Standard right lobe; WIT, Warm Ischemia Time; living donor liver transplant; natural portosystemic collateral; shunt ligation

Year:  2021        PMID: 35068782      PMCID: PMC8766688          DOI: 10.1016/j.jceh.2021.04.009

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  19 in total

1.  Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome.

Authors:  M A Yerdel; B Gunson; D Mirza; K Karayalçin; S Olliff; J Buckels; D Mayer; P McMaster; J Pirenne
Journal:  Transplantation       Date:  2000-05-15       Impact factor: 4.939

Review 2.  Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications.

Authors:  Felix Dahm; Panco Georgiev; Pierre-Alain Clavien
Journal:  Am J Transplant       Date:  2005-11       Impact factor: 8.086

3.  Effect of liver transplantation on spleen size, collateral veins, and platelet counts.

Authors:  Fumio Chikamori; Seigo Nishida; Gennaro Selvaggi; Panagiotis Tryphonopoulos; Jang I Moon; David M Levi; Tomoaki Kato; Eddie R Island; Akira Maki; Akin Tekin; Andreas G Tzakis
Journal:  World J Surg       Date:  2010-02       Impact factor: 3.352

4.  Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding.

Authors:  Qiuhe Wang; Yong Lv; Ming Bai; Zhengyu Wang; Haibo Liu; Chuangye He; Jing Niu; Wengang Guo; Bohan Luo; Zhanxin Yin; Wei Bai; Hui Chen; Enxin Wang; Dongdong Xia; Xiaomei Li; Jie Yuan; Na Han; Hongwei Cai; Tao Li; Huahong Xie; Jielai Xia; Jianhong Wang; Hongbo Zhang; Kaichun Wu; Daiming Fan; Guohong Han
Journal:  J Hepatol       Date:  2017-05-12       Impact factor: 25.083

Review 5.  Portosystemic collaterals in living donor liver transplantation: What is all the fuss about?

Authors:  Mettu Srinivas Reddy; Mohamed Rela
Journal:  Liver Transpl       Date:  2017-04       Impact factor: 5.799

6.  Obstructing spontaneous major shunt vessels might not be mandatory to maintain adequate portal inflow in living donor liver transplantation.

Authors:  Mitsuhisa Takatsuki; Zhassulan Baimakhanov; Akihiko Soyama; Yusuke Inoue; Masaaki Hidaka; Tamotsu Kuroki; Susumu Eguchi
Journal:  Transplantation       Date:  2014-05-15       Impact factor: 4.939

7.  Clinical Significance of Spontaneous Portosystemic Shunts in Living Donor Liver Transplantation.

Authors:  Marc-Antoine Allard; Nobuhisa Akamatsu; Takashi Kokudo; Kosuke Kobayashi; Junichi Kaneko; Takeaki Ishizawa; Junichi Arita; Kiyoshi Hasegawa
Journal:  Liver Transpl       Date:  2020-07-14       Impact factor: 5.799

8.  Vascular complications of orthotopic liver transplantation: experience in more than 4,200 patients.

Authors:  John P Duffy; Johnny C Hong; Douglas G Farmer; Rafik M Ghobrial; Hasan Yersiz; Jonathan R Hiatt; Ronald W Busuttil
Journal:  J Am Coll Surg       Date:  2009-05       Impact factor: 6.113

9.  Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression.

Authors:  Kwan Man; Sheung-Tat Fan; Chung-Mau Lo; Chi-Leung Liu; Peter Chin-Wan Fung; Ting-Bo Liang; Terence Kin-Wah Lee; Steven Hung-Teng Tsui; Irene Oi-Lin Ng; Zhi-Wei Zhang; John Wong
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

10.  Preoperative CT evaluation of potential donors in living donor liver transplantation.

Authors:  Sandeep Vohra; Neerav Goyal; Subash Gupta
Journal:  Indian J Radiol Imaging       Date:  2014-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.